Atypical Teratoid Rhabdoid Tumor drugs in development, 2024

GlobalData tracks 18 drugs in development for Atypical Teratoid Rhabdoid Tumor by 16 companies/universities/institutes. The top development phase for Atypical Teratoid Rhabdoid Tumor is preclinical, with six drugs in that stage.

Bayer looks to expand Kerendia label to include heart failure – Pharmaceutical Technology

The studies will receive sponsorship from the non-profit academic research organisation, CPC Clinical Research, with funding from Bayer. Image Credit: nitpicker / Shutterstock. Bayer has

September 1, 2023

Transformative epilepsy surgery gives artist new lease on life

Artist Syril Strickler was 47 when she had her first epileptic seizure, waking up in the hospital after neighbors found her unconscious in the street.

March 28, 2024

Lilly challenges Wegovy dominance in weight loss market with FDA approval – Pharmaceutical Technology

Lilly has set Zepbound’s list price in the US at $1,059.87, 20% less than that for Wegovy. Image Credit: Tada Images / Shutterstock. Eli Lilly’s

November 9, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.